143 related articles for article (PubMed ID: 27144162)
21. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
[TBL] [Abstract][Full Text] [Related]
22. Changes in endothelial microparticles and endothelial progenitor cells in obese patients in response to surgical stress.
Noci MV; Ramírez R; Lluch M; Rodríguez M; Carracedo J
J Bone Joint Surg Am; 2015 Mar; 97(5):353-8. PubMed ID: 25740024
[TBL] [Abstract][Full Text] [Related]
23. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
[TBL] [Abstract][Full Text] [Related]
24. Increased circulating red cell microparticles (RMP) and platelet microparticles (PMP) in immune thrombocytopenic purpura.
Sewify EM; Sayed D; Abdel Aal RF; Ahmad HM; Abdou MA
Thromb Res; 2013 Feb; 131(2):e59-63. PubMed ID: 23245653
[TBL] [Abstract][Full Text] [Related]
25. Interaction of platelets with endothelial progenitor cells in the experimental atherosclerosis: Role of transplanted endothelial progenitor cells and platelet microparticles.
Alexandru N; Andrei E; Dragan E; Georgescu A
Biol Cell; 2015 Jun; 107(6):189-204. PubMed ID: 25763472
[TBL] [Abstract][Full Text] [Related]
26. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Suades R; Padró T; Vilahur G; Badimon L
Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
[TBL] [Abstract][Full Text] [Related]
27. Translating the Science of Psoriasis.
Gordon KB
Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S64. PubMed ID: 27526392
[TBL] [Abstract][Full Text] [Related]
28. Berberine-induced decline in circulating CD31+/CD42- microparticles is associated with improvement of endothelial function in humans.
Wang JM; Yang Z; Xu MG; Chen L; Wang Y; Su C; Tao J
Eur J Pharmacol; 2009 Jul; 614(1-3):77-83. PubMed ID: 19401197
[TBL] [Abstract][Full Text] [Related]
29. Plasma-derived microparticles in polycythaemia vera.
Ahadon M; Abdul Aziz S; Wong CL; Leong CF
Malays J Pathol; 2018 Apr; 40(1):41-48. PubMed ID: 29704383
[TBL] [Abstract][Full Text] [Related]
30. Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden.
Lincz LF; Scorgie FE; Enjeti A; Seldon M
Thromb Res; 2012 Feb; 129(2):192-6. PubMed ID: 21798575
[TBL] [Abstract][Full Text] [Related]
31. Responses to ustekinumab in the anti-TNF agent-naïve vs. anti-TNF agent-exposed patients with psoriasis vulgaris.
Clemmensen A; Spon M; Skov L; Zachariae C; Gniadecki R
J Eur Acad Dermatol Venereol; 2011 Sep; 25(9):1037-40. PubMed ID: 21108668
[TBL] [Abstract][Full Text] [Related]
32. Platelet-derived microparticles during and after acute coronary syndrome.
Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
[TBL] [Abstract][Full Text] [Related]
33. Elevated circulating VE-cadherin+CD144+endothelial microparticles in ischemic cerebrovascular disease.
Li P; Qin C
Thromb Res; 2015 Feb; 135(2):375-81. PubMed ID: 25523345
[TBL] [Abstract][Full Text] [Related]
34. Ustekinumab: a review in the treatment of plaque psoriasis and psoriatic arthritis.
Zaghi D; Krueger GG; Callis Duffin K
J Drugs Dermatol; 2012 Feb; 11(2):160-7. PubMed ID: 22270196
[TBL] [Abstract][Full Text] [Related]
35. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
[TBL] [Abstract][Full Text] [Related]
36. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
[TBL] [Abstract][Full Text] [Related]
37. Microparticles and Kawasaki disease: a marker of vascular damage?
Guiducci S; Ricci L; Romano E; Ceccarelli C; Distler JH; Miniati I; Calabri GB; Distler O; Matucci Cerinic M; Falcini F
Clin Exp Rheumatol; 2011; 29(1 Suppl 64):S121-5. PubMed ID: 21385556
[TBL] [Abstract][Full Text] [Related]
38. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
[TBL] [Abstract][Full Text] [Related]
39. New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with erectile dysfunction and metabolic syndrome: effects of tadalafil administration.
La Vignera S
Int Angiol; 2011 Oct; 30(5):415-23. PubMed ID: 21804479
[TBL] [Abstract][Full Text] [Related]
40. Elevated platelet microparticle levels after acute ischemic stroke with concurrent idiopathic thrombocytopenic purpura.
Ichijo M; Ishibashi S; Ohkubo T; Nomura S; Sanjo N; Yokota T; Mizusawa H
J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):587-9. PubMed ID: 23747179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
